Blog Post Consumer Products Consulting Services Navigating the Bermuda Triangle of Growth This blog follows the first in our Bermuda Triangle series, “Is Your Company Stuck in the Bermuda Triangle of Growth?” My task ...
Multimedia Generics Consulting Services Quality in Generic Pharmaceuticals: Part 2 It has been almost a year since Clarkston first released its study on Quality in Generic Pharmaceuticals. Within that year, ... Download PDF
Article Biotech Consulting Services GSK Shifts Investment Towards Bioelectronics Pharmaceutical giant GSK recently announced the formation of a $50 million venture capital fund, Action Potential Venture Capital (APVC) Limited, ...
Blog Post Consulting Services Quality + Compliance Regulations, Red Tape, or Something Worse? Last week, a major pharmaceutical company, Eisai Inc., sued the Drug Enforcement Administration (DEA), the very agency that stands between ...
Blog Post Organizational Performance The Cost of Talent Mismanagement From time to time in this blog, I discuss the tremendous value of proper talent management discipline. In my most ...
Blog Post Consulting Services The Value of Life Cycle Assessment Earlier in our blog series “The Dimensions of Doing Good”, we discussed how transparency is created through Life Cycle Assessments ...
Blog Post Consulting Services The Foundation of Sustainability Reporting Connecting master data management with sustainability – is it a far reach? I don’t think so. When a company has ...
Article Generics Consulting Services Generics Manufacturers Not Liable for the Design of Drugs In the case of Mutual Pharmaceutical Co. Inc. v. Bartlett, the Supreme Court overturned a lower court ruling that awarded ...
Article Biotech Consumer Healthcare Sustainable Capitalism at the ICGN Annual Conference Fortune 500 CEO Indra Nooyi recently provided her perspectives on sustainable capitalism at the ICGN Annual Conference in New York ...
Multimedia Consulting Services Biosimilars are Coming. Are You Ready? Biosimilars are coming to the US. Although the details on the pathway for biosimilars are still being finalized, the cost ... Download PDF
Article Consumer Healthcare Consumer Products Twinkies: The Sweetest Comeback in the History of Ever The countdown is on, literally, to “the sweetest comeback in the history of ever.” Twinkies are expected to return to ...
Article Generics Consulting Services Pay-for-Delay and the Rule of Reason The economics of pay-for-delay agreements are clear – branded drug makers benefit from an extended amount of time on the ...
